Literature DB >> 6603652

HLA-DR3- and HLA-DR7-restricted T-cell hyporesponsiveness to gluten antigen: a clue to the aetiology of coeliac disease?

H Scott, H Hirschberg, E Thorsby.   

Abstract

Coeliac disease (CD) is strongly associated with the human class-II HLA determinants HLA-DR3 and -DR7. We investigated the relative frequency of gluten-reactive T cells from DR3- or DR7-positive. CD patients and healthy controls who were heterozygous at the DR locus. We found a consistently and significantly lower frequency of gluten-reactive T cells when the antigen was presented by monocytes in conjunction with DR3 or DR7 than in conjunction with the other DR determinant of the T-cell donor. In contrast, the frequency of reactive T cells in these donors to other antigens was not reduced in conjunction with DR3 or DR7. These results indicate a specific immunoregulatory function associated with class-II HLA molecules. The reduced frequency of gluten-reactive T cells in association with HLA-DR3 or -DR7 may be directly involved in the development of CD.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603652     DOI: 10.1111/j.1365-3083.1983.tb00853.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease.

Authors:  S Husby; N Foged; V A Oxelius; S E Svehag
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

2.  Genetic and clinical determinants for the T cell mediated immune response against the cornea specific protein BCP 54.

Authors:  M J Jager; H J Völker-Dieben; L de Waal; F G Kok; L Broersma; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

3.  HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects.

Authors:  O Bruserud; J Jervell; E Thorsby
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.